Cure SMA Welcomes Broad FDA Approval of Itvisma™ for Spinal Muscular Atrophy, Reinforces Commitment to Patient Access and Support
SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ — Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal…
